BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31327749)

  • 1. Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists.
    Gammal RS; Mayes J; Caudle KE
    J Am Pharm Assoc (2003); 2019; 59(5):646-650. PubMed ID: 31327749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
    Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
    J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice.
    Wang YT; Merl MY; Yang J; Zhu ZX; Li GH
    Pharmacogenomics J; 2020 Apr; 20(2):169-178. PubMed ID: 31796890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How community pharmacists envision using pharmacogenomic data: A qualitative analysis.
    Writer R; Barthen C; Antinopoulos B; Uber R; Stevenson JM; Berenbrok LA
    J Am Pharm Assoc (2003); 2021; 61(5):e64-e70. PubMed ID: 33893058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment, Implementation, and Consolidation of Clinical Pharmacy Services in Community Pharmacies: Perceptions of a Group of Pharmacists.
    Dosea AS; Brito GC; Santos LMC; Marques TC; Balisa-Rocha B; Pimentel D; Bueno D; Lyra DP
    Qual Health Res; 2017 Feb; 27(3):363-373. PubMed ID: 26658232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of pharmacy practice on community pharmacists' integration of medication and lab value information from electronic health records.
    Hughes CA; Guirguis LM; Wong T; Ng K; Ing L; Fisher K
    J Am Pharm Assoc (2003); 2011; 51(5):591-8. PubMed ID: 21896456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
    Petit C; Croisetière A; Chen F; Laverdière I
    Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
    [No Abstract]   [Full Text] [Related]  

  • 17. Knowledge of and readiness for medication therapy management among community pharmacists in Lebanon.
    Domiati S; Sacre H; Lahoud N; Sili G; Salameh P
    Int J Clin Pharm; 2018 Oct; 40(5):1165-1174. PubMed ID: 29858761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacy in Australia: a health hub destination of the future.
    McMillan SS; Wheeler AJ; Sav A; King MA; Whitty JA; Kendall E; Kelly F
    Res Social Adm Pharm; 2013; 9(6):863-75. PubMed ID: 23218552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.